CAPSTONE INVESTMENT ADVISORS, LLC
Institutional investor · Portfolio as of Q1 2020
Top Holdings1,107 positions
INVESCO QQQ TRUST SERIES 1 | 2.9M | $560.8M | 9.0% | — | — | — | Decreased — |
ISHARES MSCI EAFE ETF | 3.9M | $210.1M | 3.4% | — | — | — | Decreased — |
AMAZON.COM INC | 79,000 | $154M | 2.5% | — | — | — | Decreased — |
APPLE INC | 587,500 | $149.4M | 2.4% | — | — | — | Decreased — |
SPDR S&P 500 ETF TRUST | 472,300 | $121.7M | 2.0% | — | — | — | Decreased — |
MICROSOFT CORP | 769,300 | $121.3M | 2.0% | — | — | — | Decreased — |
SPDR S&P 500 ETF TRUST | 429,900 | $110.8M | 1.8% | — | — | — | Increased — |
ISHARES CHINA LARGE-CAP ETF | 2.8M | $104.1M | 1.7% | — | — | — | Increased — |
ISHARES RUSSELL 2000 ETF | 670,000 | $76.7M | 1.2% | — | — | — | Increased — |
FACEBOOK INC-CLASS A | 442,100 | $73.7M | 1.2% | — | — | — | Decreased — |
ISHARES MSCI EMERGING MARKET | 2.2M | $73.4M | 1.2% | — | — | — | Decreased — |
BERKSHIRE HATHAWAY INC-CL B | 269,600 | $49.3M | 0.8% | — | — | — | Decreased — |
ALLERGAN PLC | 276,400 | $49M | 0.8% | — | — | — | Increased — |
ISHARES IBOXX HIGH YLD CORP | 611,100 | $47.1M | 0.8% | — | — | — | Decreased — |
VISA INC-CLASS A SHARES | 271,300 | $43.7M | 0.7% | — | — | — | Decreased — |
EXXON MOBIL CORP | 1.1M | $42.4M | 0.7% | — | — | — | Decreased — |
MICROSOFT CORP | 247,500 | $39M | 0.6% | — | — | — | Decreased — |
UNITEDHEALTH GROUP INC | 150,900 | $37.6M | 0.6% | — | — | — | Decreased — |
ELI LILLY & CO | 259,200 | $36M | 0.6% | — | — | — | Decreased — |
ALPHABET INC-CL C | 30,500 | $35.5M | 0.6% | — | — | — | Decreased — |
CAPSTONE INVESTMENT ADVISORS, LLC manages $6.2B across 1107 positions as of Q1 2020. Top holdings: QQQ puts (9.0%), EFA puts (3.4%), AMZN puts (2.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
Active quarter - 73 new positions, 209 exits, 119 increased. No standout high-conviction moves this quarter. Portfolio: $6.2B across 1107 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR